Td Private Client Wealth LLC Vertex Pharmaceuticals Inc Transaction History

Td Private Client Wealth LLC

  • $3.48 Trillion
  • Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 13,687 shares of VRTX stock, worth $6.17 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
13,687
Previous 10,193 34.28%
Holding current value
$6.17 Million
Previous $4.78 Billion 33.24%
% of portfolio
0.18%
Previous 0.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024
BUY
$460.0 - $505.78 $1.61 Million - $1.77 Million
3,494 Added 34.28%
13,687 $6.37 Billion
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $4 Million - $4.95 Million
10,193 New
10,193 $4.78 Billion
Q1 2024

Aug 16, 2024
SELL
$407.69 - $446.08 $434,189 - $475,075
-1,065 Reduced 7.67%
12,816 $5.36 Billion
Q4 2023

Aug 16, 2024
SELL
$343.0 - $410.68 $417,088 - $499,386
-1,216 Reduced 8.05%
13,881 $5.65 Billion
Q3 2023

Aug 16, 2024
SELL
$338.18 - $362.46 $333,107 - $357,023
-985 Reduced 6.12%
15,097 $5.25 Billion
Q2 2023

Aug 16, 2024
SELL
$314.42 - $351.91 $337,372 - $377,599
-1,073 Reduced 6.25%
16,082 $5.66 Billion
Q1 2023

Aug 16, 2024
BUY
$283.23 - $323.1 $578,638 - $660,093
2,043 Added 13.52%
17,155 $5.41 Billion
Q4 2022

Aug 16, 2024
SELL
$285.76 - $321.48 $42,578 - $47,900
-149 Reduced 0.98%
15,112 $4.36 Billion
Q3 2022

Aug 16, 2024
SELL
$273.83 - $305.53 $137,736 - $153,681
-503 Reduced 3.19%
15,261 $4.42 Billion
Q2 2022

Aug 16, 2024
BUY
$234.96 - $292.55 $1.12 Million - $1.39 Million
4,750 Added 43.13%
15,764 $4.44 Billion
Q1 2022

Aug 16, 2024
BUY
$221.42 - $260.97 $68,197 - $80,378
308 Added 2.88%
11,014 $2.87 Billion
Q4 2021

Aug 16, 2024
SELL
$177.01 - $223.45 $114,879 - $145,019
-649 Reduced 5.72%
10,706 $2.35 Billion
Q3 2021

Aug 16, 2024
BUY
$181.39 - $202.99 $210,775 - $235,874
1,162 Added 11.4%
11,355 $2.06 Billion
Q2 2021

Aug 16, 2024
BUY
$187.49 - $221.1 $1.22 Million - $1.44 Million
6,516 Added 897.52%
7,242 $1.46 Billion
Q1 2021

Aug 16, 2024
SELL
$207.02 - $241.31 $1.6 Million - $1.87 Million
-7,733 Reduced 91.42%
726 $156 Million
Q4 2020

Aug 16, 2024
SELL
$207.01 - $276.09 $406,153 - $541,688
-1,962 Reduced 18.83%
8,459 $2 Billion
Q3 2020

Aug 16, 2024
BUY
$255.65 - $303.1 $16,617 - $19,701
65 Added 0.63%
10,421 $2.84 Billion
Q2 2020

Aug 16, 2024
BUY
$225.48 - $295.8 $2.16 Million - $2.83 Million
9,580 Added 1234.54%
10,356 $3.01 Billion
Q1 2020

Aug 16, 2024
BUY
$199.77 - $247.81 $23,572 - $29,241
118 Added 17.93%
776 $185 Million
Q4 2019

Aug 16, 2024
SELL
$166.71 - $223.91 $1.59 Million - $2.13 Million
-9,535 Reduced 93.54%
658 $144 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email